Additionally, we observed that PTEN and p53 gene therapy significantly increased the chemosensitivity of SW480 CRC cells, with co-transfection of PTEN + p53 notably enhancing sensitivity to oxaliplatin. The gene discussed is TP53; the disease is colorectal carcinoma.